Clinical Trials Logo
  1. Home
  2. Bone Cancer
  3. NCT01163539
  4. Details
NCT01163539 Clinical Trial

Cyberknife Radiosurgery and Quality of Life

Bone Cancer Clinical Trial

Official title:
Cyberknife Radiosurgery and Quality of Life

Clinical Trial Details — Status: Terminated

Administrative data
NCT number NCT01163539
Other study ID # SPN0002
Secondary ID SU-07092010-6499
Status Terminated
Phase N/A
First received July 14, 2010
Last updated June 29, 2016
Start date July 2010
Est. completion date June 2012

Study information
Verified date June 2016
Source Stanford University
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

The purpose of this study is to look at pain control and QOL improvement after treatment with CK Radiosurgery for spinal metastases.

Recruitment information / eligibility
Status Terminated
Enrollment 15
Est. completion date June 2012
Est. primary completion date June 2012
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients with a spinal metastasis who will be treated with Cyberknife radiosurgery.

- There are no age or gender restrictions.

- There are no life expectancy restrictions.

- Karnofsky Performance Status greater than 40.

- Negative pregnancy test or clinically assessed as not pregnant.

- Ability to understand and the willingness to sign a written informed consent document.

Exclusion Criteria:

- Patients with benign tumors will not be included (neurofibromas, schwannomas, etc.)

- Other investigational medications or treatments will be noted, but will not preclude inclusion.

- Pregnant or nursing patients will be not be included in the study due to radiation exposure.

Study Design

Observational Model: Ecologic or Community, Time Perspective: Prospective

Related Conditions & MeSH terms

Locations
Country Name City State
United States Stanford University School of Medicine Stanford California

Sponsors (1)
Lead Sponsor Collaborator
Stanford University

Country where clinical trial is conducted

United States, 

See also
  Status Clinical Trial Phase
Recruiting NCT03905174 - Massive Implants the Next Generation N/A
Completed NCT00160719 - HLA Sensitization Following Major Cortical Allograft Bone Procedures Phase 4
Completed NCT04974008 - Osteosarcoma Maintenance Therapy With OST31-164 Phase 2
Not yet recruiting NCT06070259 - Insights Into Participating in Studies for Bone Cancer
Completed NCT01553539 - Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery Phase 2
Recruiting NCT03160274 - Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
Active, not recruiting NCT02880319 - Evaluating Stereotactic Body Radiation Therapy for Oligometastatic Disease of the Bone Phase 2
Completed NCT01135849 - B-Receptor Signaling in Cardiomyopathy N/A
Terminated NCT00960063 - A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006) Phase 1
Terminated NCT02443103 - Study Evaluating the Biologic Activity of Guanabenz in Bone Metastasis N/A
Recruiting NCT04028479 - The Registry of Oncology Outcomes Associated With Testing and Treatment
Terminated NCT03525392 - Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1. Phase 1
Terminated NCT01541358 - Sodium Fluoride PET/CT for the Evaluation of Skeletal Cancer N/A
Terminated NCT01313884 - Cyclophosphamide, Doxorubicin, Vincristine w/ Irinotecan and Temozolomide in Ewings Sarcoma Phase 2
Completed NCT01091883 - Study Comparing the Safety and Effectiveness of Magnetic Resonance Guided Focused Ultrasound (MRgFUS) and External Beam Radiation (EBRT) for Treatment of Metastatic Bone Tumors and Multiple Myeloma N/A
Terminated NCT00127387 - Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia Phase 2/Phase 3
Not yet recruiting NCT03106675 - MR Imaging- Guided High Intensity Focused Ultrasound (HIFU) Therapy of Bone Metastases N/A
Recruiting NCT05830084 - Phase Ib / Regorafenib With Conventional Chemotherapy/Newly Diagnosed Patients/ Multimetastatic Ewing Sarcoma Phase 1
Completed NCT01085565 - Focused Ultrasound Surgery in the Treatment of Pain Resulting From Metastatic Bone Tumors With the ExAblate 2100 Conformal Bone System Phase 2
Recruiting NCT04307914 - Focused Ultrasound and RadioTHERapy for Noninvasive Palliative Pain Treatment in Patients With Bone Metastases N/A